Spyglass

Developer of therapies for chronic ophthalmic disorders

placeUnited States calendar_todayFounded 2020 groups15 employees language spyglasspharma.com

Registered entities

Social engagement

Social engagement: 6.4K social following, 7 posts in the last 12 months — top quartile of its industry.

Investor mix

7 investors on record; lead investors include RA Capital Management, Vensana Capital, Samsara BioCapital, Vertex Ventures HC.

Investor typeCountShare
Venture capital457%
Private equity229%
Other / undisclosed114%

Recent activity

24 Jun 2026
Event
Ophthalmology Tech Forum
2 Jun 2026
Leadership hire
Vice President, Marketing
21 May 2026
Event
Stifel Financial Corp. 2026 Virtual Ophthalmology Forum, Jefferies Global Healthcare Conference, Goldman Sachs 47th Annual Global Healthcare Conference
Coming soon